| 영문 | squamous cell carcinoma | 한글 | 편평세포암종 |
|---|---|---|---|
| 설명 | 편평세포 기원의 암으로서, 편평세포가 있는 어떤 곳에서든 발생가능함. 따라서 식도암, 피부암, 폐암, 자궁암 등이 여기에 해당된다. 특히 피부암은 많은 자외선조사에 의해 생기는 광선각화증에서 발생가능하다. 병리조직학적 특성으로서 각질을 생성한다. |
||
| LTT | lactose tolerance test; leucine tolerance test; limited treadmill test; lymphocyte transformation te... |
|---|---|
| NTZ | normal transformation zone |
| PBLT | peripheral blood lymphocyte transformation |
| PNT | partial nodular transformation; patient |
| RAEBiT, RAEB-T | refractory anemia with excess blasts in transformation |
| genome, viral | The complete gene complement contained in a DNA or RNA molecule in a virus. (12 Dec 1998) |
|---|---|
| viral | Pertaining to, caused by or of the nature of virus. (18 Nov 1997) |
| viral alkaline nuclease | <enzyme> Has both exo and endonuclease activity Registry number: EC 3.1.- Synonym: hsv type 1 alkaline nuclease, herpes simplex virus type I alkaline nuclease, alkaline nuclease, herpes simplex virus (26 Jun 1999) |
| viral antigen | Those antigens specified by the viral genome (often coat proteins) that can be detected by a specific immunological response. Often of diagnostic importance. (18 Nov 1997) |
| viral core proteins | Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the nucleocapsid. (12 Dec 1998) |
| viral cystitis | Bladder inflammation due to a viral infection. (05 Mar 2000) |
| viral dysentery | Profuse watery diarrhoea due to, or thought to be due to, infection by a virus. (05 Mar 2000) |
| viral encephalomyelitis | An encephalomyelitis due to a neurotropic virus. (05 Mar 2000) |
| viral envelope | The outer structure that encloses the nucleocapsids of some viruses; may contain host material. (05 Mar 2000) |
| viral envelope proteins | Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins. (12 Dec 1998) |
| viral fusion proteins | Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells. (12 Dec 1998) |
| viral gastroenteritis | <pathology> An inflammatory condition of the intestines that results from an infection with a virus. Rotavirus is a common cause. Abdominal pain, diarrhoea, nausea and vomiting are common symptoms. (27 Sep 1997) |
| viral haemagglutination | The nonimmune agglutination of suspended red blood cells by certain of a wide range of otherwise unrelated viruses, usually by the virion itself but in some instances by products of viral growth, the species of erythrocyte agglutinated differing with the different viruses. See: haemagglutination inhibition. (05 Mar 2000) |
| viral haemorrhagic fever | An epidemic viral illness seen in southern Sudan and Zaire, caused by the Ebola virus. The illness is characterised by fever, malaise, muscle aches, respiratory symptoms, diarrhoea, vomiting, epistaxis, haemoptysis, haematemesis, rash, tremors and subconjunctival haemorrhages. Transmitted by close bodily contact with infected individuals (blood, faeces and body fluids). Incubation is-21 days with initial symptoms of fever and headache. There is no specific treatment and death can occur within 10 days. (27 Sep 1997) |
| viral haemorrhagic fever virus | <virology> An epidemic viral illness seen in southern Sudan and Zaire, caused by the Ebola virus. The illness is characterised by fever, malaise, muscle aches, respiratory symptoms, diarrhoea, vomiting, epistaxis, haemoptysis, haematemesis, rash, tremors and subconjunctival haemorrhages. Transmitted by close bodily contact with infected individuals (blood, faeces and body fluids). Incubation is-21 days with initial symptoms of fever and headache. There is no specific treatment and death can occur within 10 days. (27 Sep 1997) |